RNF43 and nonpapillary renal cell carcinoma: Our study not only demonstrates that RNF43 serves as a prognostic indicator but alsoindicates that combining the expression of RNF43 and YAP with TNM stage or SSIGN achieves improved prognostic ability for ccRCC patients over the ability of any of the indicators alone.